Pane wikiwiki
Specify, verify and release noncanonical lipidated peptides: a request checklist, an orthogonal method matrix and risk-based acceptance criteria.
He aha ka mea e uhai ai i nā peptides lipidated noncanonical i nā manaʻo hoʻohālikelike maʻamau

"Noncanonical" a me "lipidated" wehewehe ʻelua mau koi hoʻolālā ʻokoʻa, a me kahi noi e mālama iā lākou me he mea lā ʻaʻole i kuhikuhi ʻia ma mua o ka haʻalele ʻana i kāu pākaukau. ʻO ka axis mua ke koena noncanonical: he poloka hale kūlohelohe ʻole a mimetic paha e pani ana i kahi waikawa amino proteinogenic. ʻO ka lua, ʻo ia ka lipid noncanonical a i ʻole kemika linker, e uhi ana i ka dicarboxylic-acid-enabled a me ka cleavable lipid concepts a me PEG-lipid hybrids. Hoʻonohonoho nā mea kūʻai aku i kēia mau menus ʻokoʻa, No laila, ʻo kahi noi e hoʻopaʻa inoa "he lipidated noncanonical peptide" e waiho i ka mea hoʻolako e koho i nā mea ʻelua (Nā Peptides Makakū).
Aia ka hoʻoholo ʻelua ma lalo o kēlā māhele: inā paha e hele ana ka lipid ma luna o ka resini a ma hope paha o ka wehe ʻana i ka hoʻonā. Ke kaumaha hydrophobicity, ʻO ka loiloi pūʻulu palekana a me ka pilikia o ka haumia nā loli āpau me kēlā koho, no laila aia i loko o ka kikoʻī a i ʻole i kahi ʻelele kikoʻī i ka mea hoʻolako (Nā Peptides Makakū).

Hōʻike ka chemistry i ke kumu o ke kumu kūʻai o ka ambiguity. ʻO ka hoʻohuihui paʻa paʻa o kēia manawa me ka HATU a i ʻole HBTU reagents hiki 99 i 99.5 pākēneka no ka hoʻohui ʻana, akā, e holo ana kēlā me kēia pōʻai ma 3 i 10 ka nui o ka reagent (ʻAmelika Peptides, 2026-06-06). Ma luna o kahi kaʻina lipophilic lōʻihi, e hui pū ʻia ke koena pae i loko o kahi ukana haumia maoli. ʻO ka hōʻuluʻulu ʻana ma-resin ke ʻano hemahema nui no nā kaʻina hydrophobic, me ka hoʻohaʻahaʻa haʻahaʻa i ka maikaʻi o ka hui ʻana a me ka hoʻonui ʻana i ka holoi ʻana i nā haumia i loko o ka n-1, n-2 a me n-3 moʻo (Bio-Syn).
Ki Takeaway: E wehewehe i ke koena kemika noncanonical a me ka kemika lipid/linker ma ke ʻano he ʻelua koi kaʻawale, a e hōʻike i ka hopena o ka lipidation ma ka resin a i ʻole ma hope o ka wehe ʻana.
He aha ka mea e pono e wehewehe ʻia i loko o kahi noi ʻana i ka Peptide Synthesis

ʻO kahi noi peptide synthesis maʻamau e like me ka maikaʻi e like me nā kahua e lawe ai. E waiho i kahi hakahaka a hoʻopiha ka mea kūʻai aku me kahi paʻamau āu i koho ʻole ai. ʻO nā kīhāpai e pono ai e lawe i kahi noi kuʻuna-synthesis piha ke kaʻina N-to-C piha, ʻO kēlā me kēia koena noncanonical i kapa ʻia me ka stereochemistry (ʻAno-D, N-methyl, β-amino ʻakika), ʻike lipid, wahi hoʻopili, mea hoʻohui a i ʻole kemika conjugation, pahu hoʻomaʻemaʻe, unahi, a me nā mea hoʻopuka analytical (Bachem; Thermo Fisher Scientific).

|
kahua kikoʻī |
No ke aha ia mea |
He aha ke kumu kūʻai |
|---|---|---|
|
N-to-C kaʻina |
Wehewehe i ka pahuhopu synthetic |
Hoʻololi ka mea kūʻai aku i ke koena kauoha paʻamau |
|
Koena noncanonical, me ka stereochemistry |
D-form a me N-methyl hoʻololi i nā kinetics hui pū |
Racemization a i ʻole nā moku isomer hewa |
|
ʻIkepili lipid |
C12 vs C18:1 hoʻololi i ka solubility a me ka lawelawe ʻana |
ʻO ka papa lipid hewa, hiki ole ke hoohana |
|
Lae hoʻopili |
N-manawa, Lys e-amine, ʻO ka lima Cys, a i ʻole koena helu kuhikuhi |
ʻAina lipid ma ka pae hewa |
|
Mea hoʻohui/conjugation chemistry |
Amide, ester, thioester, thioether, ʻokoʻa ke ʻano o ka disulfide |
Hoʻopili paʻa ʻole, ʻokiʻoki mua |
|
Nā lawelawe Pahu hoʻomaʻemaʻe |
Hoʻohuihui Peptide Hoʻokuʻu i ka manawa hoʻomaʻemaʻe a me ke kumukūʻai |
Ma lalo- a i ʻole ka papa i hōʻike ʻia |
|
Ka unahi a me ka aliquoting |
Hoʻonohonoho i ka synthesis a me ka hoʻolālā hoʻopili |
ʻAʻole lawa nā mea no ka hana hou ʻana |
|
Nā mea hoʻopuka hoʻopukapuka |
Wehewehe i ka pūʻolo ʻikepili hoʻokuʻu |
ʻAʻohe hōʻike no ka hailona |
Hāʻawi maʻamau nā ʻano lāʻau lipidation a me nā papa lipid i kahi hoa synthesis i ka span amide, ester, thioester, thioether, a me nā loulou disulfide, me ka hoʻopili ʻana ma ka N-terminus, Lys e-amine, he lima Cys, a i ʻole nā koena hydroxyl, a me kahi papa ʻelele o lauric C12, myristic C14, palmitic C16, stearic C18, oleic C18:1, a me nā sterols e like me ka cholesterol (Nā Peptides Makakū).
Pono nā māla ʻelua i nā helu kikoʻī ma mua o kahi ākea āu e manaʻo ai e wehewehe ka mea kūʻai aku. Hoʻopili ʻia nā papahele maʻemaʻe: maluna 95% no NMR, crystallography, receptor-ligand, a me nā hoʻokūkū hoʻokūkū; 90 i 95% no ka hana monoclonal-antibody a me ka quantitative ELISA a i ʻole RIA; maluna 80% no ka hoʻopaʻa ʻana i ka Western non-quantitative, i loko o kahi holoʻokoʻa 80% i 97% hui no ka hana ʻole GMP (ʻO ke alakaʻi hoʻomaʻemaʻe i kuhikuhi ʻia e Bachem). E nānā i ke kumu: he ʻaoʻao kūʻai kēia e kūʻai aku ana i nā māka kiʻekiʻe, no laila e mālama i nā papahele ma ke ʻano he hoʻomaka, ʻaʻole kahi hōʻailona kūʻokoʻa.
ʻO ka unahi ka hahai ʻana i ka loina like. ʻO ka pālākiō a me ke ʻano aliquoting i hoʻopuka ʻia e ka mea kūʻai aku synthesis maʻamau 5 mg i 100 g, me ke aliquoting mai 0.5 mg no ka vial ma ± 2% pololei a me ka hoʻokuʻu ʻana QC maʻamau e HPLC me MALDI-MS (Bachem). Mea kūʻai like, hooikaika like: hōʻoia i ka papa hoʻokuʻu āu e pono ai ma mua o kou ʻae ʻana i ka paʻamau.
Aia ma ke kākau ʻana i hoʻokahi hoʻoholo ala. E hōʻike inā hoʻokomo ʻia ka lipid ma ka resin a ma hope paha o ka ʻoki ʻana, a i ʻole e hāʻawi i kēlā koho ma mua o ka haʻalele ʻana. ʻO ka hāʻawi ʻana i ka hoʻoholo ala ma mua o ka haʻalele ʻana ʻo ia ka mea e mālama ai i ka mea kūʻai mai ka hoʻonui ʻana i kā lākou ala synthesis haʻahaʻa loa ma mua o kāu assay..
No ke kōkua: Hoʻopili i kēia pākaukau i kāu noi ʻōlelo a noi i ka mea kūʻai aku e hōʻoia a paʻi paha i kēlā me kēia lālani. ʻO ka hoʻopaʻapaʻa kākau he manaʻo i kākau ʻia; ʻaʻole ʻo ka hamau.
[Kiʻi kiʻi: palapala kauoha kuʻuna-synthesis i hōʻike ʻia me nā kahua kikoʻī i hōʻike ʻia]
Pehea e hōʻoia ai i ka lipidation kikoʻī o ka pūnaewele a me kahi i loaʻa mai ai ka ambiguity

Hoʻopaʻa ka nuipaʻa paʻa i ka haku mele ʻana, ʻaʻole kūlana. Hōʻike ka hoʻololi ʻike ʻia iā ʻoe i kahi conjugate i hoʻokumu ʻia a pili i ka nui o ka lipid i hoʻohui ʻia; aole, iaia iho, hoʻoholo i ka kikoʻī pūnaewele, wehewehe kikoʻī, a i ʻole nā isomers kūlana haʻahaʻa. Pono ka localization i ka peptide-level a i ʻole subunit-level hana e LC-MS/MS a i ʻole nā ala pili (Mea hoʻomohala proteomics, Intact Mass Analysis for Conjugation Conjugation, 2026-03-12). ʻO kēlā ʻōlelo hoʻokahi ke kumu ʻoi aku ka paʻakikī o ka hōʻoia ʻana i ka lipidation kikoʻī ma mua o ka mea: Hiki i nā ʻāpana ʻelua ke kaʻana like i ka nui like a ʻokoʻa i kahi e noho ai ka lipid.
E hahai ana ka lula escalation no ka ʻikepili intact-mass mai kēlā palena. Ua lawa ʻo MALDI-TOF no ka hōʻoia ʻae a ʻaʻole hoʻohuihui. E hoʻonui i ka ESI-MS a i ʻole LC-MS ke kau ʻia nā ʻano, nā mokuʻāina noho lehulehu, a i ʻole e ʻike ʻia nā envelopes ākea, a mālama i kahi alapiʻi o nā envelopes kokoke loa i hōʻailona o nā wahi he nui a i ʻole nā mea hoʻohui ma mua o ka pilikia maʻemaʻe. (Mea hoʻomohala proteomics, 2026-03-12).
ʻO ka pūʻolo hōʻike ʻehā ʻāpana no ka lipidation kikoʻī kikoʻī he synthesis o kēia mau kumu o luna ma mua o kahi kumu i ʻōlelo ʻia.: ka paena pololei i hoakakaia ma ka manao, he pāʻani nui LC-MS a HRMS paha, digest me LC-MS/MS ka palapala ʻāina pūnaewele e hōʻike ana i ka lipid ma ka ʻāpana i manaʻo ʻia, a me nā hōʻike e ʻike ʻole ana nā wahi ʻē aʻe a i ʻole ma lalo o kahi paepae kūpono.
Kahi e hōʻemi ai nā ʻano analytical ʻo Orthogonal i ka Ambiguity i ka noiʻi mua
ʻO ka nīnau kūpono ʻaʻole ʻo ia ka mea ʻoi aku ka maikaʻi, akā ʻo kēlā mau ʻano hana e uhi i kahi makapō o kekahi. Hōʻikeʻike Orthogonal, ʻaʻole hoʻokahi hoʻāʻo, ʻO ia ka mea e hoʻonui ai i ka hilinaʻi i ka wā e hiki ai i kahi peptide lipidated ke lilo i mau molekole like ʻole.
Hāʻawi ka spectrometry mass hoʻonā kiʻekiʻe i ka haku mele a me nā ion precursor ma mua o ka ʻāpana, He mea nui ia ke kaʻana like nā ʻano isobaric i ka nuipa inoa. Noho ʻo NMR i ke kua i ka wā ʻaʻole hiki iā MS ke hoʻokaʻawale i ka ambiguity isomeric a regioisomeric. ʻO ka hoʻohālikelike ʻana i ka koho C18 a me C4 e hoʻohui i kahi lua o ka hoʻokaʻawale ʻana, no ka mea, ua hoʻoholo nā ʻāpana kū ʻelua i nā ʻano me ka hydrophobicity ʻokoʻa. E noʻonoʻo i ia mea ma ke ʻano he alakaʻi alakaʻi ma mua o kahi ʻōlelo i hōʻoia ʻia: ʻaʻole hiki ke wehe ʻia ka palapala kumu i kēia holo.
ʻOi aku ka ʻike o ka hōʻike ʻana i ka haumia ma mua o ka helu maʻemaʻe hoʻokahi. Hoʻopuka ka lipidation i ka acylation piha ʻole, over-acylation, nā isomers kūlana a me nā ʻano pili pili, a me nā mea hoʻolako e hōʻike paʻa i nā ʻano like ʻole, kaʻina-pili, a i ʻole ka hoʻohālikelike-pili, ma hope o nā ʻaha ICH Q3A/Q3B (Nā Peptides Makakū). No ka hōʻike ʻana i ka lipopeptide, e nīnau i nā papa haumia i hiki i ka palapala hōʻoia ke inoa maoli.
|
ʻano hana |
ʻO ka mea e hōʻoiaʻiʻo ai |
ʻO ka mea hiki ʻole ke hōʻoia |
E hoʻonui i ka wā |
|---|---|---|---|
|
Nuipa paʻa |
Kūlike ke kaumaha molekala i ke kūkulu i manaʻo ʻia |
Ma kahi e noho ai ka lipid, a i ʻole e noho pū ana nā isomers |
Pākuʻi nui akā ʻaʻole i manaʻo ʻia ka hana a i ʻole ka paʻa ʻana |
|
LC-MS/MS ma hope o ka ʻeli ʻana |
Ke kaʻina a me ka paena hoʻololi i nā ʻāpana i ʻike ʻia |
ʻAʻole i loaʻa ka hoʻololi ʻana i nā ʻāpana |
ʻO nā ʻāpana uhi e waiho i ke koena lipidated me ka nānā ʻole ʻia |
|
HRMS |
ʻO ka haku mele a me nā ion precursor ma mua o MS/MS |
ʻokoʻa ʻokoʻa a i ʻole regioisomeric |
He kūpono nā ʻano Isobaric |
|
NMR |
ʻO ka hana hoʻolālā kahi hiki ʻole iā MS ke hoʻonā i nā isomers |
Hoʻokuʻu ʻia ka hailona maʻamau ma ka pālākiō |
ʻAʻole kānalua ka ʻikepili MS ma ka hoʻopili |
|
Orthogonal RP-HPLC (C18 vs. C4) |
Hoʻokaʻawale ʻokoʻa mai nā hoʻololi hydrophobicity |
ʻO ka ʻike hoʻonohonoho piha |
Hōʻike kekahi ʻano i ka piko hoʻokahi, ʻaʻole hana kekahi |
Ka Hoʻonohonoho ʻana i nā Koina ʻae ʻia ma muli o ka pilikia no kahi Lota Lipidated
Pono e kūkulu ʻia nā pae hoʻokuʻu no kahi ʻāpana lipidated mai ka mea a ka mea e hana ai, ʻaʻole mai kahi pahuhopu maʻemaʻe i kope ʻia mai kahi ʻaoʻao papa inoa. No ka nui o ka noiʻi mua ʻana, ʻO ka ʻae ʻana ma mua o kahi helu maʻemaʻe ʻo ia ka ʻike o nā ʻano lipidated pololei, he ʻike peptide i ʻike ʻia e ka helu helu e like me ka nānā ʻana i ka waikawa amino, he ʻano paʻakai a me ka ʻike kūʻē me kona nui, a me kahi wai i hōʻike ʻia. Me ka ʻole o kēlā mau mea, ʻO ka nuipa āu e kaupaona ai he mau mea ʻaʻole peptide.
ʻO ia ke kumu o nā mea laina analytical a ka mea kūʻai aku i ʻōlelo ʻokoʻa: ʻO ka waihona peptide net e AAA a i ʻole CHN, ka wai a me ka ʻakika, mea kūʻē, ʻO ka ESI-MS/MS a me ka hoʻāʻo endotoxin hiki ke hōʻike ʻia a kūʻai ʻia kēlā me kēia ma kā lākou iho. Hōʻike ʻo Thermo Fisher maʻamau-peptide QC i ka pae like: MS me HPLC no nā peptides maʻamau, MS me ka HPLC analytical a me AAA no nā peptides kaumaha, me nā mea i hoʻouna ʻia ma ke ʻano he paʻakai TFA lyophilized ke ʻole ke noi ʻia kahi ʻano ʻē aʻe. ʻO nā ʻaoʻao ʻelua nā mea kūʻai aku me ka hoʻoikaika e kūʻai aku i nā mea hoʻohui, no laila e mālama iā lākou ma ke ʻano he papa kuhikuhi, ʻaʻole kahi hōʻailona.
ʻO ke kahua no ke koho ʻana i nā palena ICH Q6A ka ʻae ʻana-koʻikoʻi hoʻolālā, pono 1 Mei 2000, e kamaʻilio ana i ke ʻano o ka hoʻonohonoho ʻana a me ka ʻae ʻia o nā pae hoʻoholo a me nā kaʻina hana hoʻāʻo. Ma ka hoʻomaʻamaʻa ʻana kēia ka hoʻonohonoho kikoʻī kūpono i ka pae: he kaʻina hana pilikia QbD e palapala ʻana i ka ʻokoʻa i ka pilikia o ka huahana ma mua o ka lula helu hoʻokahi.
⚠️ ʻŌlelo Aʻo: Hoʻopili ka CoA i nā hopena i kahi pūʻulu kikoʻī, e lawe ana i ka helu hailona, kaʻina, HPLC maemae, ʻIkepili MS, nā kikoʻī ala a me ka chromatogram a i ʻole spectrum, pinepine me ka waihona peptide net, lā hoʻāʻo a me ka hale hana. ʻAʻohe mea pili i kahi pepa kikoʻī "maʻamau".. Inā ʻaʻole inoa ka palapala i kāu ʻāpana, ʻaʻole ia he hōʻike hōʻike no kāu mea.
Nā hewa maʻamau i hoʻopololei i kahi papahana noncanonical lipidated peptide
ʻO nā hāʻule kūʻai nui loa ma kēia kaʻina hana ʻaʻole nā hemahema synthesis. ʻO lākou nā kikoʻī a me ka hoʻokuʻu ʻana i nā hemahema: Ua hoʻokō ka hailona i kāna mau ʻōlelo i ʻōlelo ʻia a ʻaʻole hiki ke kākoʻo i ka hoʻokolohua i kauoha ʻia ai. Ua kākau ʻia kēlā me kēia kuhi hewa ma lalo nei ma ke ʻano he loiloi loiloi, no laila hiki iā ʻoe ke nānā i kāu noi ponoʻī ma mua o ka hoʻomaka ʻana o ka mea kūʻai aku.
Ka mālama ʻana i ka nuipaʻa paʻa ma ke ʻano he hōʻoia o ke koho ʻana i ka pūnaewele. Hoʻopaʻa ka nuipaʻa paʻa i ka haku mele ʻana, ʻaʻole kūlana. ʻO ka hailona-matched i hāʻule mau nō ka hihia archetypal: aia ka lipid, pololei ke kaumaha mole, a ke kau nei ka hoʻololi ʻana i ke koena hewa, no laila ua hala ka hailona e hoʻokuʻu a hāʻule i ka hoʻāʻo. E nīnau i nā mea hōʻike e pili ana i ka lipid, ʻaʻole i ka mea hōʻike i kaupaona ʻia.
Hōʻike i kahi helu maʻemaʻe hoʻokahi. ʻO kahi helu maʻemaʻe e hūnā ana i nā isomers kūlana a me nā ʻano over-acylate e haʻi iā ʻoe he nui ka piko nui, ʻaʻole ʻo ia ka molekala kūpono. ʻO ka maʻemaʻe a me ka koho ʻana i ka pūnaewele he mau ana ʻokoʻa, a hiki i kahi kiʻi maʻemaʻe kiʻekiʻe ke noho pū me kahi huahana heterogeneous.
Ke waiho nei i ka hoʻoholo ala ʻaʻole i haʻi ʻia. ʻO kahi hoʻoholo ala ala ʻole i hoʻoholo ʻia e ka mea kūʻai aku no ka hoʻohua ʻana he hoʻololi mālie o ka mana ma luna o kāu ʻaoʻao haumia.. E hōʻike i ka hopena o ka lipidation ma ka resin a i ʻole ma hope o ka wehe ʻana, a e ʻōlelo i nā ʻano ʻano āu e pono ai e hoʻopau.
Ke kāpae ʻana i ka stereochemistry no nā koena noncanonical. ʻAʻole hiki ke hōʻoia ʻia ka diastereomer āu i makemake ai ma ka loaʻa ʻana mai ka Stereochemistry, no ka mea, ʻaʻohe mea i loko o ka kikoʻī e hoʻokaʻawale iā ia mai ka mea āu i loaʻa ai.
ʻO ka ʻae ʻana i kahi CoA i pili ʻole i ka hailona. ʻAʻole hiki ke ʻike ʻia kahi CoA i hoʻopaʻa ʻole ʻia i ka hailona i ka mea i loko o kāu pahu hau, ka mea e wehe ai i kou hiki ke noiʻi ma hope.
Hōʻike ka hāʻule ʻana o ka hui ʻana i kahi ʻano ʻike ʻia: nā piko HPLC ākea a māhele paha, ka nuipaʻa like i nā manawa paʻa he nui, paʻakikī e hoʻokaʻawale i nā haumia kokoke i nā hoalauna, ʻano like ʻole o ka pūʻulu, a ʻaʻole hiki ke hoʻoheheʻe ʻia ma hope o ka ʻoki ʻana (Bio-Syn, heluhelu 2026). ʻO kēia nā heuristic hoʻoponopono pilikia ma mua o ka paʻi ʻana i nā helu hāʻule, akā, ʻo ia ka hōʻailona hōʻino maʻamau o kahi kaʻina lipophilic a pono ke nānā aku i kekahi chromatogram āu e loaʻa ai..
|
Kuhihewa |
No ke aha ia mea |
ʻO ka hoʻoponopono |
|---|---|---|
|
Heluhelu ʻia ka lehulehu ma ke ʻano he hōʻoia o ke koho ʻana i ka pūnaewele |
ʻO ka nuipa ke ana maʻalahi loa e hōʻike a nānā pono |
Pono i nā hōʻike hoʻokaʻawale, ʻaʻole haku mele wale |
|
Hookahi helu maemae no ka hailona holookoa |
ʻO ka maʻemaʻe ka metric hoʻokuʻu maʻamau |
E hōʻike i ka maʻemaʻe a me ke koho ʻana i ka pūnaewele ma ke ʻano he hopena kaʻawale |
|
Waiho ʻia ka hoʻoholo ala i ka mea kūʻai aku |
ʻAʻole hōʻike ka noi i kahi mea nui o ka haumia |
E wehewehe ma-resin a ma hope paha, a me nā ʻano mea e hoʻopau ai |
|
Hōʻike ʻole ʻia ka Stereochemistry |
Manaʻo ʻia nā koena noncanonical ʻaʻole maopopo |
E hōʻike i ka diastereomer a me ke ʻano e hoʻokaʻawale ai |
|
ʻAʻole pili nui ʻo CoA |
Hana ʻia ka palapala ma ke ʻano he hana |
E hōʻole i kekahi CoA e hana ʻO nā Peptides Synthetic ʻaʻole ʻike i ka nui |
He aha ka holomua a pehea e heluhelu ai i ka pūʻolo ʻikepili
ʻAʻole helu maʻemaʻe ka hailona i hoʻopau ʻia. He pūʻolo hōʻike ʻehā ʻāpana no ka lipidation kikoʻī kikoʻī: he palapala hōʻoia no ka nānā ʻana i pili i kēlā pūʻulu kikoʻī, he nuipaʻa paʻa i kūpono i ka conjugate i manaʻo ʻia, he palapala ʻāina digest-a-LC-MS/MS e kau ana i ka lipid ma luna o ka ʻāpana i manaʻo ʻia me nā wahi ʻē aʻe i ʻole a i ʻole ma lalo o kahi paepae i ʻōlelo ʻia., a me ka hōʻike ʻana i ka ʻike peptide net, ʻike kūʻē a me ka ʻike wai. ʻO kēlā ʻāpana hope ka mea i hoʻopaʻa ʻia e kahi CoA i hoʻopaʻa ʻia. Me ka ʻole, ke ʻae nei ka mea heluhelu i nā manaʻo e pili ana i ka ʻae ʻana ma mua o ka helu maʻemaʻe.
E heluhelu i ka pūʻolo ma ia ʻano. ʻIke mua, no ka mea, ʻaʻole hiki i kahi pāʻani nui wale ke hoʻololi i kahi hoʻololi. Ka lua o ka palapala 'āina, no ka mea, ʻo ia wale nō ka mea e hoʻokaʻawale ai i ka isomer kūlana i manaʻo ʻia mai kahi ʻokoʻa like ʻole. Maʻiʻo a me ka counterion ke kolu, no ka mea, hoʻoholo lākou i ka nui o nā mea i loko o ka vial.
No ka hailona mua o ka hana hou, mālama i ka hōʻailona orthogonal, ʻaʻole hoʻokahi hoʻāʻo, e like me ke kūlana hana: holo i kahi kaʻawale orthogonal e like me C18 me C4, a hoʻohui i kahi backstop NMR kahi e pono ai ke kūkulu. hale kūʻai I ka manawa e hōʻike ʻia ai ke kūlike ʻana o ka nui-a-lot, hiki i ka papa hana maʻamau ke lawe i ka hoʻokuʻu. E hoʻomanaʻo, aia ke alakaʻi ʻana i ka ʻāpana orthogonal ma ka hōʻoia hapa, no laila e mālama iā ia ma ke ʻano he hana hōʻemi pilikia ma mua o kahi protocol i hōʻoia ʻia.
Ki Takeaway: Pono nā hoʻoholo hoʻokuʻu e hahai i kahi kaʻina i wehewehe ʻia: hui ka maemae a me ka ike, a laila hui ka palapala ʻāina, a laila hōʻike ʻia ka ʻike a me ka counterion. He lālā i hāʻule i nā ala e piʻi ai a loiloi, ʻaʻole hōʻole ʻakomi. E pili ana
He kiʻi kiʻi pae kaʻina: he kaʻina hana analytical e kākoʻo ana i ka hōʻike ʻana i hui pū ʻia a hiki ke hoʻohana ʻia no ka mālama ʻana i ka palapala ʻāina, ʻO ka ʻikepili a me ka counterion i loko o hoʻokahi moʻolelo hoʻokuʻu e kōkua i ka poʻe loiloi e huli i kēlā me kēia koi i ka hailona i loaʻa mai ai. MOL Changes hana ma kēia wahi ma ke ʻano he hoa hana peptide synthesis maʻamau.
Nīnau pinepine
Pehea ka lōʻihi o ka hana maʻamau no kanonical lipidated peptide synthesis?
E hoʻolālā no ka lōʻihi ma mua o ka manawa peptide maʻamau. Hoʻopuka pinepine ʻia kahi kauoha peptide maʻamau ma kahi o ʻelua a ʻekolu mau pule no ka lawe ʻana, a ke kuhi nei kēlā kumu i nā koena maʻamau a me ka hoʻomaʻemaʻe pololei. Kemika lipidation, ʻimi ʻana i nā koena noncanonical, a me ka hooikaika chromatographic hou e koi ana ke kaulahao hydrophobic i kela a me keia e hookuke i ka papa kuhikuhi. E noi i kāu mea hoʻolako no kahi papa hana milestone e hoʻokaʻawale i ka synthesis, lipidation, a me ka hoomaemae ana, no laila ʻike ʻia kahi paheʻe ma kahi pae hoʻokahi ma mua o ka lilo ʻana i lohi hoʻouna.
Ua lawa ka nuipaʻa paʻa e hōʻoia i ka lipidation kikoʻī o ka pūnaewele?
ʻAʻole. Hōʻike ʻo Intact mass iā ʻoe i ka nui o ke kaumaha molekala o ke kūkulu, ʻaʻole ma kahi e noho ai ka lipid. Hiki ke lawe i ke kaulahao ma ke koena hewa, a ʻokoʻa ke ʻano o kēlā isomer kūlana i ka hoʻopaʻa ʻana a i ʻole ka hoʻopaʻa paʻa. E mālama i ka nuipa paʻa ma ke ʻano he puka hoʻokuʻu no ka ʻike wale nō, a laila e piʻi i ka palapala kiʻekiʻe peptide i ka wā e pono ai ka pūnaewele. He maʻalahi ka lula escalation: Ua lawa ʻo MALDI-TOF no ka nānā ʻana i ka lehulehu wikiwiki, akā pono ka hōʻoia ʻana o ka lipidation kikoʻī i ka pūnaewele ESI a i ʻole LC-MS me ka ʻāpana, no ka mea, ʻo ka hoʻokolohua tandem wale nō ke hoʻololi i ka hoʻololi.
He aha inā pili ka nui akā ʻaʻole like ka palapala ʻāina?
ʻO ia ka hihia kūlana-isomer, a ʻaʻole hiki ke hoʻokuʻu ʻia ka hailona no ka hana pili pūnaewele. E noi i ka ʻikepili palapala kiʻekiʻe peptide ma mua o ka ʻae ʻana, a e hoohalike i na mahele C18 a me C4, no ka mea, ʻokoʻa ka hoʻoholo ʻana o nā mea kemika ʻelua i nā ʻano lipopeptide. Inā mau ka ʻokoʻa isomeric ma hope o ka hoʻokaʻawale orthogonal, e noʻonoʻo i ka NMR e hoʻokaʻawale pololei i ka hoʻololi. Hana ʻia ʻo Peptide
Ke pani nei ka papa maʻemaʻe kiʻekiʻe i nā hōʻike koho koho pūnaewele?
ʻAʻole. ʻO ka maʻemaʻe a me ka ʻike pūnaewele he mau ʻano orthogonal. He helu maemae hookahi, ʻo kekahi i hōʻike ʻia ma 98%, Hiki iā ia ke hūnā i nā isomers kūlana a me nā ʻano over-acylate e hui pū me ka pahuhopu. E noi i ka chromatogram a me ka ʻikepili palapala ma hope o ka helu, ʻaʻole wale ka pākēneka.
He aha kaʻu e hana ai inā pili ka lipidated peptide me kahi ʻano ʻoki?
E hoʻololi i ka hoʻokaʻawale ʻana ma mua o ka paepae ʻae. Hiki i ke kaʻina ʻoki ʻia i nele i kahi ʻāpana o ke kaulahao lipid hiki ke hahai pono me ka huahana holoʻokoʻa ma kahi gradient C18 maʻamau., no laila, ʻo ke ala e hoʻoponopono ai iā lākou ʻo ka hoʻoponopono kūpono. E ho'āʻo i kahi ʻanuʻu pāpaʻu a i ʻole kahi pae kū ʻokoʻa, a hōʻoia i nā piko i hoʻoholo ʻia e ka nui ma mua o kou hoʻokuʻu ʻana i ka hailona.
Ka hopena
Loaʻa iā ʻoe ʻekolu mau mea hana no ka noncanonical lipidated peptides: he papa helu kiko'ī e koi ana i ka noi e haʻi i ke koena, ka lipid, a me ke kemika hoʻopili; he matrix hōʻoia e hoʻokaʻawale i nā mea a kēlā me kēia ala e hōʻoia ai mai ka mea hiki ʻole; a me nā pae hoʻohālike e pili ana i ka pilikia e hoʻonui i ka hōʻike i ka hopena o ka hewa. ʻO ka maʻamau kiʻekiʻe-waiwai e hoʻopaʻa pū iā lākou he maʻalahi: Mai hoʻokuʻu wale i ka nui paʻa i loko no ke koho ʻana i ka pūnaewele. He hui nui, Hiki i ka hailona maʻemaʻe kiʻekiʻe ke lawe i ka lipid ma ke koena hewa.
Inā makemake ʻoe e heluhelu ʻelua ma kahi kūkulu ma mua o ka hana ʻana i kahi ala, noi i kahi loiloi kūkulu a e hele pū mākou me ʻoe i ka kikoʻī a me ka ʻae ʻana.
Hana ʻo MOL Changes me nā hui noiʻi e pili ana i ka synthesis peptide maʻamau a me ke ʻano, no laila, loaʻa iā mākou kahi hoihoi pāʻoihana i nā kūlana maikaʻi peptide. ʻO ke kaʻina hana ma luna e kū ponoʻī me ka nānā ʻole i ka mea hoʻolako.
